1. 5-Aryl indanones and derivatives as non-steroidal progesterone receptor modulators
- Author
-
Matthew R. Yudt, Richard C. Winneker, Yuan Zhu, Puwen Zhang, Jeffrey I. Cohen, Terefenko Eugene Anthony, Eugene John Trybulski, Zhiming Zhang, Jeffrey Curtis Kern, and Thomas J. Berrodin
- Subjects
Agonist ,medicine.drug_class ,Stereochemistry ,Clinical Biochemistry ,Pharmaceutical Science ,Biochemistry ,Chemical synthesis ,chemistry.chemical_compound ,Structure-Activity Relationship ,Drug Discovery ,Progesterone receptor ,medicine ,Molecular Biology ,Molecular Structure ,Organic Chemistry ,Antagonist ,Biological activity ,Stereoisomerism ,Oxime ,chemistry ,Nuclear receptor ,Drug Design ,Indans ,Molecular Medicine ,Alkaline phosphatase ,Receptors, Progesterone - Abstract
Novel 5-aryl indanones, inden-1-one oximes, and inden-1-ols were synthesized and evaluated as progesterone receptor (PR) modulators using the T47D cell alkaline phosphatase assay. Both PR agonists and antagonists were achieved with appropriate 3- and 5-substitution from indanones and inden-1-ols while inden-1-one oximes provided only PR antagonists. Several compounds such as 10 and 11 demonstrated potent in vitro PR agonist potency similar to that of steroidal progesterone (1). In addition, a number of compounds (e.g., 12, 13, 17, 18) showed potent PR antagonist activity indicating the indanones and derivatives are promising PR modulator templates.
- Published
- 2009